Home

Richard E. Lowenthal, President and CEO: ARS Pharmaceuticals SPRY Sell · Filed 24/11/21

Trade details

Type
Insider sale
Amount
$697,500
Shares · price
50,000 sh · $13.95 a share
Held after
1,198,499 sh
Trade date
24/11/19
Filed
24/11/21
Days to filing
2 days

Sold 4.0% of holdings

Share of holding sold
4.0%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/10/20~24/12/19

Richard E. Lowenthal's recent trades

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $177K

    Filed 09/11

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $421.1K

    Filed 09/04

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $115.6K

    Filed 09/03

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $5,000

    Filed 09/02

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $148.2K

    Filed 08/20